Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Systemic multipotent adult progenitor cells improve long-term neurodevelopmental outcomes after preterm hypoxic-ischemic encephalopathy.

Barkhuizen M, van Mechelen R, Vermeer M, Chedraui P, Paes D, van den Hove DLA, Vaes B, Mays RW, Steinbusch HWM, Robertson NJ, Kramer BW, Gavilanes AWD.

Behav Brain Res. 2019 Apr 19;362:77-81. doi: 10.1016/j.bbr.2019.01.016. Epub 2019 Jan 10.

2.

Multipotent Adult Progenitor Cells, but Not Tissue Inhibitor of Matrix Metalloproteinase-3, Increase Tissue Sparing and Reduce Urological Complications following Spinal Cord Injury.

Jones JM, DePaul MA, Gregory CR, Lang BT, Xie H, Zhu M, Rutten MJ, Mays RW, Busch SA, Pati S, Gregory KW.

J Neurotrauma. 2019 May 1;36(9):1416-1427. doi: 10.1089/neu.2018.5727. Epub 2018 Dec 4.

PMID:
30251917
3.

Intravenous Cellular Therapies for Acute Ischemic Stroke.

Mays RW, Savitz SI.

Stroke. 2018 May;49(5):1058-1065. doi: 10.1161/STROKEAHA.118.018287. Epub 2018 Apr 18. Review. No abstract available.

PMID:
29669867
4.

Therapeutic time window of multipotent adult progenitor therapy after traumatic brain injury.

Bedi SS, Aertker BM, Liao GP, Caplan HW, Bhattarai D, Mandy F, Mandy F, Fernandez LG, Zelnick P, Mitchell MB, Schiffer W, Johnson M, Denson E, Prabhakara K, Xue H, Smith P, Uray K, Olson SD, Mays RW, Cox CS Jr.

J Neuroinflammation. 2018 Mar 16;15(1):84. doi: 10.1186/s12974-018-1122-8.

5.

Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.

Donders R, Bogie JFJ, Ravanidis S, Gervois P, Vanheusden M, Marée R, Schrynemackers M, Smeets HJM, Pinxteren J, Gijbels K, Walbers S, Mays RW, Deans R, Van Den Bosch L, Stinissen P, Lambrichts I, Gyselaers W, Hellings N.

Stem Cells Dev. 2018 Jan 15;27(2):65-84. doi: 10.1089/scd.2017.0029. Epub 2017 Dec 21.

PMID:
29267140
6.

Crosstalk with Inflammatory Macrophages Shapes the Regulatory Properties of Multipotent Adult Progenitor Cells.

Ravanidis S, Bogie JFJ, Donders R, Deans R, Hendriks JJA, Stinissen P, Pinxteren J, Mays RW, Hellings N.

Stem Cells Int. 2017;2017:2353240. doi: 10.1155/2017/2353240. Epub 2017 Jul 12.

7.

Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.

Hess DC, Wechsler LR, Clark WM, Savitz SI, Ford GA, Chiu D, Yavagal DR, Uchino K, Liebeskind DS, Auchus AP, Sen S, Sila CA, Vest JD, Mays RW.

Lancet Neurol. 2017 May;16(5):360-368. doi: 10.1016/S1474-4422(17)30046-7. Epub 2017 Mar 17.

PMID:
28320635
8.

Multipotent Adult Progenitor Cells Enhance Recovery After Stroke by Modulating the Immune Response from the Spleen.

Yang B, Hamilton JA, Valenzuela KS, Bogaerts A, Xi X, Aronowski J, Mays RW, Savitz SI.

Stem Cells. 2017 May;35(5):1290-1302. doi: 10.1002/stem.2600. Epub 2017 Mar 6.

9.

Multipotent adult progenitor cells for hypoxic-ischemic injury in the preterm brain.

Jellema RK, Ophelders DR, Zwanenburg A, Nikiforou M, Delhaas T, Andriessen P, Mays RW, Deans R, Germeraad WT, Wolfs TG, Kramer BW.

J Neuroinflammation. 2015 Dec 23;12:241. doi: 10.1186/s12974-015-0459-5.

10.

Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury.

DePaul MA, Palmer M, Lang BT, Cutrone R, Tran AP, Madalena KM, Bogaerts A, Hamilton JA, Deans RJ, Mays RW, Busch SA, Silver J.

Sci Rep. 2015 Nov 19;5:16795. doi: 10.1038/srep16795.

11.

Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells.

Ravanidis S, Bogie JF, Donders R, Craeye D, Mays RW, Deans R, Gijbels K, Bronckaers A, Stinissen P, Pinxteren J, Hellings N.

Stem Cell Res Ther. 2015 Sep 16;6:176. doi: 10.1186/s13287-015-0169-z.

12.

Intravenous multipotent adult progenitor cell therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury.

Bedi SS, Hetz R, Thomas C, Smith P, Olsen AB, Williams S, Xue H, Aroom K, Uray K, Hamilton J, Mays RW, Cox CS Jr.

Stem Cells Transl Med. 2013 Dec;2(12):953-60. doi: 10.5966/sctm.2013-0100. Epub 2013 Nov 4.

13.

A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke.

Hess DC, Sila CA, Furlan AJ, Wechsler LR, Switzer JA, Mays RW.

Int J Stroke. 2014 Apr;9(3):381-6. doi: 10.1111/ijs.12065. Epub 2013 May 22.

PMID:
23692637
14.

Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: modulation of the resident microglia population.

Walker PA, Bedi SS, Shah SK, Jimenez F, Xue H, Hamilton JA, Smith P, Thomas CP, Mays RW, Pati S, Cox CS Jr.

J Neuroinflammation. 2012 Sep 28;9:228. doi: 10.1186/1742-2094-9-228.

15.

Intracerebroventricular transplantation of human bone marrow-derived multipotent progenitor cells in an immunodeficient mouse model of mucopolysaccharidosis type I (MPS-I).

Nan Z, Shekels L, Ryabinin O, Evavold C, Nelson MS, Khan SA, Deans RJ, Mays RW, Low WC, Gupta P.

Cell Transplant. 2012;21(7):1577-93.

PMID:
22472595
16.

Update on stem cell therapy for cerebral palsy.

Carroll JE, Mays RW.

Expert Opin Biol Ther. 2011 Apr;11(4):463-71. doi: 10.1517/14712598.2011.557060. Epub 2011 Feb 8. Review.

17.

Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury.

Busch SA, Hamilton JA, Horn KP, Cuascut FX, Cutrone R, Lehman N, Deans RJ, Ting AE, Mays RW, Silver J.

J Neurosci. 2011 Jan 19;31(3):944-53. doi: 10.1523/JNEUROSCI.3566-10.2011.

18.

Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes.

Walker PA, Shah SK, Jimenez F, Gerber MH, Xue H, Cutrone R, Hamilton JA, Mays RW, Deans R, Pati S, Dash PK, Cox CS Jr.

Exp Neurol. 2010 Oct;225(2):341-52. doi: 10.1016/j.expneurol.2010.07.005. Epub 2010 Jul 15.

19.

3-Indolyl sultams as selective CRTh2 antagonists.

Tumey LN, Robarge MJ, Gleason E, Song J, Murphy SM, Ekema G, Doucette C, Hanniford D, Palmer M, Pawlowski G, Danzig J, Loftus M, Hunady K, Sherf B, Mays RW, Stricker-Krongrad A, Brunden KR, Bennani YL, Harrington JJ.

Bioorg Med Chem Lett. 2010 Jun 1;20(11):3287-90. doi: 10.1016/j.bmcl.2010.04.046. Epub 2010 Apr 14.

PMID:
20457519
20.

Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats.

Yasuhara T, Hara K, Maki M, Mays RW, Deans RJ, Hess DC, Carroll JE, Borlongan CV.

J Cereb Blood Flow Metab. 2008 Nov;28(11):1804-10. doi: 10.1038/jcbfm.2008.68. Epub 2008 Jul 2.

21.

Therapeutic pathways of adult stem cell repair.

Ting AE, Mays RW, Frey MR, Hof WV, Medicetty S, Deans R.

Crit Rev Oncol Hematol. 2008 Jan;65(1):81-93. Epub 2007 Nov 26. Review.

PMID:
18032062
22.

Development of adult pluripotent stem cell therapies for ischemic injury and disease.

Mays RW, van't Hof W, Ting AE, Perry R, Deans R.

Expert Opin Biol Ther. 2007 Feb;7(2):173-84. Review.

PMID:
17250456
23.

Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury.

Yasuhara T, Matsukawa N, Yu G, Xu L, Mays RW, Kovach J, Deans RJ, Hess DC, Carroll JE, Borlongan CV.

Cell Transplant. 2006;15(3):231-8.

PMID:
16719058
24.

Transplantation of cryopreserved human bone marrow-derived multipotent adult progenitor cells for neonatal hypoxic-ischemic injury: targeting the hippocampus.

Yasuhara T, Matsukawa N, Yu G, Xu L, Mays RW, Kovach J, Deans R, Hess DC, Carroll JE, Borlongan CV.

Rev Neurosci. 2006;17(1-2):215-25.

PMID:
16703953
25.

Identification of a novel extracellular cation-sensing G-protein-coupled receptor.

Pi M, Faber P, Ekema G, Jackson PD, Ting A, Wang N, Fontilla-Poole M, Mays RW, Brunden KR, Harrington JJ, Quarles LD.

J Biol Chem. 2005 Dec 2;280(48):40201-9. Epub 2005 Sep 30.

26.

Isosteric ramatroban analogs: selective and potent CRTH-2 antagonists.

Robarge MJ, Bom DC, Tumey LN, Varga N, Gleason E, Silver D, Song J, Murphy SM, Ekema G, Doucette C, Hanniford D, Palmer M, Pawlowski G, Danzig J, Loftus M, Hunady K, Sherf BA, Mays RW, Stricker-Krongrad A, Brunden KR, Harrington JJ, Bennani YL.

Bioorg Med Chem Lett. 2005 Mar 15;15(6):1749-53.

PMID:
15745833
27.
28.

5-a-day Power Plus: process evaluation of a multicomponent elementary school program to increase fruit and vegetable consumption.

Story M, Mays RW, Bishop DB, Perry CL, Taylor G, Smyth M, Gray C.

Health Educ Behav. 2000 Apr;27(2):187-200.

PMID:
10768800
29.
30.

Changing fruit and vegetable consumption among children: the 5-a-Day Power Plus program in St. Paul, Minnesota.

Perry CL, Bishop DB, Taylor G, Murray DM, Mays RW, Dudovitz BS, Smyth M, Story M.

Am J Public Health. 1998 Apr;88(4):603-9.

31.

Formation of de novo centromeres and construction of first-generation human artificial microchromosomes.

Harrington JJ, Van Bokkelen G, Mays RW, Gustashaw K, Willard HF.

Nat Genet. 1997 Apr;15(4):345-55.

PMID:
9090378
32.

Hierarchy of mechanisms involved in generating Na/K-ATPase polarity in MDCK epithelial cells.

Mays RW, Siemers KA, Fritz BA, Lowe AW, van Meer G, Nelson WJ.

J Cell Biol. 1995 Sep;130(5):1105-15.

33.

Generation of epithelial cell polarity: roles for protein trafficking, membrane-cytoskeleton, and E-cadherin-mediated cell adhesion.

Mays RW, Nelson WJ, Marrs JA.

Cold Spring Harb Symp Quant Biol. 1995;60:763-73. Review. No abstract available.

PMID:
8824451
34.

Organization and function of the cytoskeleton in polarized epithelial cells: a component of the protein sorting machinery.

Mays RW, Beck KA, Nelson WJ.

Curr Opin Cell Biol. 1994 Feb;6(1):16-24. Review.

PMID:
8167021
35.
36.

Response.

Siemers Krzeminski KA, Wilson Hammerton R, Mays RW, Ryan TA, Wollner DA, Nelson WJ.

Science. 1993 Apr 23;260(5107):554-6. No abstract available.

PMID:
17830435
37.

Mechanisms for regulating the cell surface distribution of Na/K-ATPase in polarized epithelial cells.

Mays RW, Nelson WJ.

Chest. 1992 Mar;101(3 Suppl):50S-52S. No abstract available.

PMID:
1311669
38.

Mechanism for regulating cell surface distribution of Na+,K(+)-ATPase in polarized epithelial cells.

Hammerton RW, Krzeminski KA, Mays RW, Ryan TA, Wollner DA, Nelson WJ.

Science. 1991 Nov 8;254(5033):847-50.

PMID:
1658934
39.
40.

Food eaten by athletes.

MAYS RW, SCOULAR FI.

J Am Diet Assoc. 1961 Sep;39:225-7. No abstract available.

PMID:
13768629

Supplemental Content

Support Center